LpxC inhibitors: a patent review (2010-2016)

dc.contributor.author	Kalinin, Dmitrii V.
dc.contributor.author	Holl, Ralph
dc.date.accessioned	2019-06-25T09:24:41Z
dc.date.available	2019-06-25T09:24:41Z
dc.date.issued	2017
dc.identifier.issn	1744-7674
dc.identifier.uri	http://hdl.handle.net/10900/89879
dc.language.iso	en	de_DE
dc.publisher	Taylor & Francis Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1080/13543776.2017.1360282	de_DE
dc.subject.ddc	540	de_DE
dc.subject.ddc	610	de_DE
dc.title	LpxC inhibitors: a patent review (2010-2016)	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_04281
utue.publikation.seiten	1227-1250	de_DE
utue.personen.roh	Kalinin, Dmitrii V.
utue.personen.roh	Holl, Ralph
dcterms.isPartOf.ZSTitelID	Expert Opinion on Therapeutic Patents	de_DE
dcterms.isPartOf.ZS-Issue	11	de_DE
dcterms.isPartOf.ZS-Volume	27	de_DE